Foghorn Therapeutics Market Cap

Foghorn Therapeutics has a market cap or net worth of $337.43 million as of March 6, 2026. Its market cap has increased by 3.37% in one year.

Market Cap

337.43M

Enterprise Value

167.38M

1-Year Change

3.37%

Ranking

#3412

Market Cap Chart

Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $337.43M, a decrease of -40.32%. That is a compound annual growth rate of -9.17%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	330.40M	8.19%
Dec 31, 2025	305.38M	16.38%
Dec 31, 2024	262.40M	-3.64%
Dec 29, 2023	272.30M	2.10%
Dec 30, 2022	266.70M	-68.56%
Dec 31, 2021	848.32M	17.59%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Neurogene	342.79M
Greenwich LifeSciences	341.79M
Adlai Nortye	340.96M
Opus Genetics	328.96M
Avalo Therapeutics	325.45M
Rezolute	325.12M
Relmada Therapeutics	324.87M
X4 Pharmaceuticals	323.52M

Market Cap Rankings